Provided by Tiger Trade Technology Pte. Ltd.

VolitionRX

0.1715
-0.0285-14.25%
Post-market: 0.1714-0.0001-0.06%19:59 EDT
Volume:6.94M
Turnover:1.23M
Market Cap:27.18M
PE:-0.78
High:0.1928
Open:0.1928
Low:0.1700
Close:0.2000
52wk High:0.9400
52wk Low:0.1700
Shares:158.48M
Float Shares:115.00M
Volume Ratio:0.91
T/O Rate:6.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2200
EPS(LYR):-0.2200
ROE:-730.06%
ROA:-166.70%
PB:-0.79
PE(LYR):-0.78

Loading ...

VolitionRx and Fujifilm Vet Systems Validate Automated Nu.Q Vet Cancer Test in Japan

Reuters
·
Mar 06

Volition Announces First Ever Automated Nu.q® Vet Cancer Test With Fujifilm Vet Systems

THOMSON REUTERS
·
Mar 06

VolitionRx reports progress on Capture-Seq, Nu.Q lung cancer reimbursement, and Nu.Q NETs sepsis program in France

Reuters
·
Feb 25

VolitionRX Issues Unregistered Shares to Lind Global Asset Management XII LLC

Reuters
·
Feb 21

VolitionRX Appoints MBL as Distributor for Nu.Q Discover Assays in Japan

Reuters
·
Feb 10

VolitionRx Faces NYSE American Non-Compliance Notice Over Equity Requirements

Reuters
·
Feb 10

VolitionRX Receives Notice of Non-Compliance With Nyse American Continued Listing Standards

THOMSON REUTERS
·
Feb 10

VolitionRx Unveils Clinical Study Showing Nu.Q NETs Blood Test Guides Hidradenitis Suppurativa Treatment

Reuters
·
Feb 04

VolitionRX Limited Announces the Preparation of Reimbursement Submission for Its Nu.q® Cancer Assays

THOMSON REUTERS
·
Jan 30

VolitionRX Ltd: Once Reimbursement Achieved Anticipate Introduction of Nu.q Into Routine Clinical Use in France by Q4, 2026

THOMSON REUTERS
·
Jan 30

VolitionRx Unveils Study Supporting Nu.Q NETs Blood Test for Hidradenitis Suppurativa Management

Reuters
·
Jan 28

Volition Announces Data to Support Use of Nu.q® Nets in New Indication

THOMSON REUTERS
·
Jan 27

VolitionRX Ltd. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Jan 27

VolitionRX Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 21

VolitionRX Expands Nu.Q Vet Cancer Test Access With New Laboratory Providers

Reuters
·
Jan 20

VolitionRX Ltd. Showcases Nu.Q Vet Cancer Test at VMX Veterinary Conference

Reuters
·
Jan 16

VolitionRX Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jan 09

BRIEF-Volitionrx Ltd Enters Amended Securities Purchase Agreement

Reuters
·
Jan 08

VolitionRX Ltd - Enters Amended Securities Purchase Agreement

THOMSON REUTERS
·
Jan 08

VolitionRX Ltd - to Receive $2,000,000 From Investor

THOMSON REUTERS
·
Jan 08